Business Context and Reporting Period
This Form 8-K is a current report filed by Bristol-Myers Squibb Company on March 17, 2017. The filing addresses a specific corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a disclosure of personnel changes and does not contain financial performance data.
Material Changes
The material change disclosed is the departure of a director:
- Item 5.02: Secretary Togo D. West, Jr. notified the company on March 17, 2017, that he will not stand for re-election to the Board of Directors.
- The 2017 Annual Meeting of Shareholders, where this change would take effect, is expected to be held on May 2, 2017.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a notification of the director's decision not to seek re-election.
Key Facts for Investor Verification
- Confirm the exact date of the 2017 Annual Meeting of Shareholders (expected May 2, 2017).
- Verify if a replacement director has been nominated to fill the vacancy left by Togo D. West, Jr.
- Review the company's proxy statement for the 2017 Annual Meeting for further details on board composition.